Ja. Thliveris et al., PREVENTION OF INSULIN-DEPENDENT DIABETES-MELLITUS BY 2'-DEOXYCOFORMYCIN IN THE BB WISTAR RAT, Biochemical pharmacology, 46(6), 1993, pp. 1071-1075
The effect of the adenosine deaminase (ADA) inhibitor 2'-deoxycoformyc
in (dCF) on the development of insulin-dependent diabetes mellitus (ID
DM) was assessed in the BB Wistar rat. Sixty-one male rats were treate
d from days 30 to 120 with 0, 0.5, 1.0 or 1.5 mg dCF/kg/week. The inci
dence of IDDM was 78% in the controls and was significantly (P < 0.01)
decreased in rats receiving 1.5 mg dCF/kg/week (32%), but not in rats
receiving lower doses of the drug. However, for those rats that becam
e diabetic the mean time to the development of IDDM was unchanged in a
nimals receiving dCF compared with control. dCF treatment did not prod
uce significant weight loss in the animals or gross changes in the thy
mus, spleen or kidneys. Although the protective effect of dCF against
IDDM was likely produced by immunosuppression, the different dCF dosag
es had similar effects on ADA suppression in spleen or thymus and on d
ATP accumulation in these organs.